| Profile | GDS5420 / 224994_at |
| Title | Psoriasis response to brodalumab: dose response and time course |
| Organism | Homo sapiens |
| Sample | Title | Value | Rank |
|---|---|---|---|
| GSM1296094 | A_lesional_pre-dose | 90.62 | 40 |
| GSM1296119 | B_lesional_pre-dose | 830.91 | 76 |
| GSM1296076 | C_lesional_pre-dose | 922.43 | 78 |
| GSM1296092 | D_lesional_pre-dose | 422.81 | 66 |
| GSM1296103 | E_lesional_pre-dose | 138.62 | 47 |
| GSM1296078 | F_lesional_pre-dose | 910.21 | 78 |
| GSM1296107 | G_lesional_pre-dose | 896.74 | 78 |
| GSM1296109 | H_lesional_pre-dose | 460.28 | 66 |
| GSM1296080 | I_lesional_pre-dose | 86.16 | 41 |
| GSM1296090 | J_lesional_pre-dose | 687.69 | 73 |
| GSM1296074 | K_lesional_pre-dose | 764.55 | 75 |
| GSM1296111 | L_lesional_pre-dose | 1027.26 | 80 |
| GSM1296099 | M_lesional_pre-dose | 293.18 | 58 |
| GSM1296086 | O_lesional_pre-dose | 434.3 | 66 |
| GSM1296117 | P_lesional_pre-dose | 898.92 | 78 |
| GSM1296113 | Q_lesional_pre-dose | 809.86 | 76 |
| GSM1296096 | R_lesional_pre-dose | 332 | 61 |
| GSM1296105 | S_lesional_pre-dose | 210.36 | 52 |
| GSM1296098 | T_lesional_pre-dose | 117.28 | 43 |
| GSM1296101 | U_lesional_pre-dose | 113.6 | 43 |
| GSM1296121 | V_lesional_pre-dose | 714.13 | 74 |
| GSM1296088 | W_lesional_pre-dose | 264.58 | 57 |
| GSM1296082 | X_lesional_pre-dose | 700.43 | 74 |
| GSM1296115 | Y_lesional_pre-dose | 914.31 | 78 |
| GSM1296084 | Z_lesional_pre-dose | 296.75 | 59 |
| GSM1296072 | B_lesional_day8 | 634.36 | 72 |
| GSM1296069 | L_lesional_day8 | 1256.22 | 83 |
| GSM1296071 | P_lesional_day8 | 696.44 | 73 |
| GSM1296070 | Y_lesional_day8 | 864.9 | 77 |
| GSM1296073 | V_lesional_day8 | 734.36 | 74 |
| GSM1296034 | A_lesional_day15 | 70.43 | 35 |
| GSM1296041 | G_lesional_day15 | 970.48 | 79 |
| GSM1296035 | R_lesional_day15 | 308.29 | 59 |
| GSM1296038 | U_lesional_day15 | 327.78 | 61 |
| GSM1296047 | B_lesional_day15 | 672.96 | 73 |
| GSM1296039 | E_lesional_day15 | 470.92 | 67 |
| GSM1296042 | H_lesional_day15 | 947.95 | 79 |
| GSM1296043 | L_lesional_day15 | 959.06 | 79 |
| GSM1296037 | M_lesional_day15 | 197.61 | 51 |
| GSM1296046 | P_lesional_day15 | 902.16 | 78 |
| GSM1296044 | Q_lesional_day15 | 739.33 | 74 |
| GSM1296045 | Y_lesional_day15 | 1078.25 | 81 |
| GSM1296025 | C_lesional_day15 | 162.17 | 49 |
| GSM1296033 | D_lesional_day15 | 218.52 | 54 |
| GSM1296027 | I_lesional_day15 | 204.38 | 54 |
| GSM1296032 | J_lesional_day15 | 306.51 | 59 |
| GSM1296024 | K_lesional_day15 | 131.68 | 46 |
| GSM1296031 | W_lesional_day15 | 532.89 | 68 |
| GSM1296028 | X_lesional_day15 | 286.25 | 58 |
| GSM1296029 | Z_lesional_day15 | 394.1 | 63 |
| GSM1296026 | F_lesional_day15 | 230.04 | 55 |
| GSM1296030 | O_lesional_day15 | 160.44 | 51 |
| GSM1296040 | S_lesional_day15 | 122.97 | 44 |
| GSM1296036 | T_lesional_day15 | 98.06 | 40 |
| GSM1296048 | V_lesional_day15 | 704.57 | 74 |
| GSM1296059 | A_lesional_day43 | 167.91 | 50 |
| GSM1296066 | G_lesional_day43 | 931.31 | 78 |
| GSM1296060 | R_lesional_day43 | 303.52 | 59 |
| GSM1296063 | U_lesional_day43 | 635.82 | 72 |
| GSM1296064 | E_lesional_day43 | 475.34 | 67 |
| GSM1296067 | H_lesional_day43 | 617 | 71 |
| GSM1296062 | M_lesional_day43 | 87.73 | 39 |
| GSM1296068 | Q_lesional_day43 | 752.75 | 75 |
| GSM1296050 | C_lesional_day43 | 667.43 | 73 |
| GSM1296057 | D_lesional_day43 | 263.65 | 57 |
| GSM1296052 | I_lesional_day43 | 248.71 | 57 |
| GSM1296054 | J_lesional_day43 | 203.51 | 52 |
| GSM1296049 | K_lesional_day43 | 198.63 | 53 |
| GSM1296055 | W_lesional_day43 | 638.69 | 72 |
| GSM1296053 | X_lesional_day43 | 139.04 | 47 |
| GSM1296058 | Z_lesional_day43 | 208.24 | 53 |
| GSM1296051 | F_lesional_day43 | 610.27 | 71 |
| GSM1296056 | O_lesional_day43 | 370.75 | 63 |
| GSM1296065 | S_lesional_day43 | 521.9 | 68 |
| GSM1296061 | T_lesional_day43 | 153.38 | 47 |
| GSM1296095 | A_non-lesional_pre-dose | 431.22 | 65 |
| GSM1296120 | B_non-lesional_pre-dose | 724.36 | 74 |
| GSM1296077 | C_non-lesional_pre-dose | 221.03 | 55 |
| GSM1296093 | D_non-lesional_pre-dose | 160.61 | 48 |
| GSM1296104 | E_non-lesional_pre-dose | 520.34 | 69 |
| GSM1296079 | F_non-lesional_pre-dose | 420.58 | 65 |
| GSM1296108 | G_non-lesional_pre-dose | 741.28 | 74 |
| GSM1296110 | H_non-lesional_pre-dose | 644.64 | 72 |
| GSM1296081 | I_non-lesional_pre-dose | 186.02 | 52 |
| GSM1296091 | J_non-lesional_pre-dose | 611.84 | 71 |
| GSM1296075 | K_non-lesional_pre-dose | 556.63 | 70 |
| GSM1296112 | L_non-lesional_pre-dose | 944.85 | 79 |
| GSM1296100 | M_non-lesional_pre-dose | 151.93 | 47 |
| GSM1296087 | O_non-lesional_pre-dose | 260.37 | 58 |
| GSM1296118 | P_non-lesional_pre-dose | 652.02 | 72 |
| GSM1296114 | Q_non-lesional_pre-dose | 821.26 | 76 |
| GSM1296097 | R_non-lesional_pre-dose | 387.62 | 63 |
| GSM1296106 | S_non-lesional_pre-dose | 351.23 | 61 |
| GSM1296102 | U_non-lesional_pre-dose | 201.06 | 51 |
| GSM1296122 | V_non-lesional_pre-dose | 647.91 | 72 |
| GSM1296089 | W_non-lesional_pre-dose | 582.79 | 70 |
| GSM1296083 | X_non-lesional_pre-dose | 177.47 | 50 |
| GSM1296116 | Y_non-lesional_pre-dose | 1007.42 | 80 |
| GSM1296085 | Z_non-lesional_pre-dose | 191.86 | 52 |